Skip to main content Deutsch

Collaborations

Sorry, this content is only available in German!

National and international research clusters

The laboratory is participating in several national and international research clusters:

SFB-F70

My group is part of the special research program (SFB-F70) “HDACs as regulators of T cell-mediated immunity in health and disease” which is a newly established research network funded by the Austrian Science Fund. It is formed by an interdisciplinary consortium of eight research groups. The overall aim of this 8-year SFB research program and consortium is to provide an immunological and molecular rationale for using sub-class-specific and isoform-selective HDAC inhibitors in the treatment of T cell-mediated diseases.

www.meduniwien.ac.at/HIT/

Immunology Research Cluster

The Immunology Research Cluster (IRC) is a network of more than 80 research groups at the Medical University of Vienna with a strong research focus on Allergy, Inflammation & Infection. The overall aim of the IRC is to strengthen the research environment and support in the field of Immunology and to foster translational approaches for the benefit of the patient. In addition, IRC members are dedicated at providing excellent research and training opportunities for PhD students and postdoctoral fellows.

cluster.meduniwien.ac.at/irc

Ludwig Boltzman Institute

My group has established a collaboration with the Ludwig Boltzman Institute for Arthritis and Rehabilitation. The research programs of the institute are addressing questions of clinical and translational research in the fields of rheumatology and rehabilitation. The focus of basic and translational research is on chondrocyte biology and development of novel drugs for treatment of inflammatory and degenerative joint disorders.

crbr.lbg.ac.at/tags/cluster

RTCure

The Division of Rheumatology is part of the RTCure project, which aims to develop new tolerizing treatment strategies for Rheumatoid Arthritis patients in the earliest stages of the disease as well as those at risk for developing Rheumatoid Arthritis. Therefore, the team has set the goal to develop and validate new methods to identify patients at high risk for Rheumatoid Arthritis and tools to monitor the progress of the diseases.

www.imi.europa.eu/projects-results/project-factsheets/rtcure